One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1136/jitc-2020-sitc2020.0433
Copy DOI
Export
Save
Share
Cite Journal: Journal for ImmunoTherapy of Cancer |  Publication Date: Nov 1, 2020 |
 Citations: 5 |  License type: open-access |
Affiliation: Roswell Park Cancer Institute, Amgen (United States), Mount Sinai Hospital, University of California, Los Angeles, Angeles Clinic and Research Institute, Indiana University Health, Indiana University – Purdue University Indianapolis, University of Iowa Hospitals and Clinics, University of North Carolina at Chapel Hill, Rutgers, The State University of New Jersey, The University of Texas MD Anderson Cancer Center, James Graham Brown Foundation, Kiel University, Mayo Clinic
BackgroundThis is the first randomized trial evaluating an oncolytic virus with an immune checkpoint inhibitor in advanced melanoma. Improved objective response rate (ORR) was observed for T-VEC plus IPI compared...
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
